Get started
Author

Daniela Ottaviani

Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01
2019 · Guillem Pascual-Pasto, Miriam Bazan-Peregrino, et al. · Science Translational Medicine · 118
A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression
2021 · Jing Liu, Daniela Ottaviani, et al. · Nature Communications · 105
PDF
Clinical, Genomic, and Pharmacological Study of MYCN-Amplified RB1 Wild-Type Metastatic Retinoblastoma
2020 · Santiago Zugbi, Daiana Ganiewich, et al. · Cancers · 45
PDF
Association of Cone-Rod Homeobox Transcription Factor Messenger RNA With Pediatric Metastatic Retinoblastoma
2015 · Ana V. Torbidoni, Viviana E. Laurent, et al. · JAMA Ophthalmology · 33
PDF
Genomic and Transcriptomic Tumor Heterogeneity in Bilateral Retinoblastoma
2020 · Ursula Winter, Daiana Ganiewich, et al. · JAMA Ophthalmology · 26
PDF
Minimal Disseminated Disease in Nonmetastatic Retinoblastoma With High-Risk Pathologic Features and Association With Disease-Free Survival
2016 · Viviana E. Laurent, Ana Vanesa Torbidoni, et al. · JAMA Ophthalmology · 26
PDF
Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma
2021 · Rosario Aschero, Jasmine Francis, et al. · Cancers · 23
PDF
Spectrum ofRB1Mutations in Argentine Patients: 20-years Experience in the Molecular Diagnosis of Retinoblastoma
2013 · Daniela Ottaviani, Diana Parma, et al. · Ophthalmic Genetics · 17
Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma
2023 · Rosario Aschero, Daiana Ganiewich, et al. · Pediatric Blood & Cancer · 13
PDF
RET overexpression leads to increased brain metastatic competency in luminal breast cancer
2024 · Petra Jagust, Aoibhin M Powell, et al. · JNCI Journal of the National Cancer Institute · 12
Dynamic epi‐transcriptomic landscape mapping with disease progression in estrogen receptor‐positive breast cancer
2023 · Stephen Keelan, Mihaela Ola, et al. · 癌症：英文版 · 11
PDF
Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer
2025 · Daniela Ottaviani, Mihaela Ola, et al. · JNCI Journal of the National Cancer Institute · 6
Establishment and Comprehensive Characterization of a Novel Preclinical Platform of Metastatic Retinoblastoma for Therapeutic Developments
2023 · Santiago Zugbi, Rosario Aschero, et al. · Investigative Ophthalmology & Visual Science · 6
PDF
Molecular diagnosis of dystrophinopathies using a multi‐technique analysis algorithm
2013 · Leonela N. Luce, Daniela Ottaviani, et al. · Muscle & Nerve · 6
Uncommon RB1 somatic mutations in a unilateral retinoblastoma patient.
2015 · Daniela Ottaviani, Cristina Alonso, et al. · PubMed · 3
Mutations in the RB1 Gene in Argentine Retinoblastoma Patients and Uncommon Clinical Presentations
2014 · Ottaviani Daniela Parma Diana · Journal of Genetic Disorders & Genetic Reports · 2
Response to Lehrer
2026 · Damir Varešlija, Daniela Ottaviani, et al. · JNCI Journal of the National Cancer Institute
Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer (RNA-seq: siCDK12 FPKM normalised counts for all samples)
2025 · Ottaviani, Daniela, Ola, Mihaela, et al. · Figshare
Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer (ChIP-seq: siCDK12 binding peaks as detected using MACS2 in narrowPeak mode)
2025 · Ottaviani, Daniela, Ola, Mihaela, et al. · Figshare
Insights into the biological effect of targeting CDK12 in advanced ER+ breast cancer
2024 · A. Allotta, S. Kalsi, et al. · European Journal of Cancer
PDF
Immunohistochemical expression of TFF1 is a new prognostic marker in retinoblastoma
2023 · Rosario Aschero, Daiana Ganiewich, et al. · medRxiv
PDF
Cover Image, Volume 43, Issue 5
2023 · Stephen Keelan, Mihaela Ola, et al. · 癌症：英文版
PDF
Abstract 2500: Metastatic retinoblastoma exhibit MYCN alterations, recurrent CNAs and hypomethylation as molecular characteristics of aggressive disease
2022 · Daiana Ganiewich, Santiago Zugbi, et al. · Cancer Research
In-Depth Characterization of Human Retinoblastoma Subtype 2 and Preclinical Models
2019 · Daniela Ottaviani · HAL
PDF
In-Depth Characterization of Human Retinoblastoma Subtype 2 and Preclinical Models
2019 · Daniela Ottaviani
Works count: 28
Citation count: 452
H-index: 11
I10-index: 11
Year
Topic
Type